Drugs / EFIZONERIMOD ALFA
EFIZONERIMOD ALFA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02221960 | Sep 2014 → Jul 2017 | — | MedImmune LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EFIZONERIMOD ALFA | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990030 ↗ |
| Known as | Efizonerimod | ChEMBL registry synonym — accepted as the source's own label CHEMBL3990030 ↗ |
| Known as | MEDI6383 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02221960 ↗ |